AHL
NVO

Abel Hall LLC’s Novo Nordisk NVO Stock Holding History

Abel Hall LLC’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$920K Buy
19,198
+13,124
+216% +$564K 0.16% 94
2026
Q1 		$223K Sell
6,074
-8,778
-59% -$416K 0.05% 561
2025
Q4 		$756K Buy
14,852
+6,923
+87% +$354K 0.18% 90
2025
Q3 		$440K Buy
7,929
+1,724
+28% +$101K 0.18% 110
2025
Q2 		$428K Buy
6,205
+1,184
+24% +$80.5K 0.2% 105
2025
Q1 		$349K Sell
5,021
-992
-16% -$81.9K 0.21% 84
2024
Q4 		$517K Buy
6,013
+206
+4% +$22.3K 0.33% 43
2024
Q3 		$691K Buy
5,807
+162
+3% +$21.6K 0.45% 33
2024
Q2 		$806K Buy
5,645
+388
+7% +$51.4K 0.57% 30
2024
Q1 		$675K Buy
5,257
+212
+4% +$25.2K 0.51% 32
2023
Q4 		$522K Buy
+5,045
New +$499K 0.45% 35

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
GIM
Generate Investment Management Auckland, New Zealand $2.43B AUM 37.24% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return

Abel Hall LLC's NVO Position: Q2 2026 in Review

Abel Hall LLC increased its Novo Nordisk (NVO) stake by 216% in Q2 2026, buying an estimated $564K and bringing the position to 19,198 shares worth $920K. The position accounts for 0.16% of the portfolio, ranked #94.

Abel Hall LLC first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. 484 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Abel Hall LLC held 19,198 shares of Novo Nordisk worth $920K as of Q2 2026.
  • Abel Hall LLC bought 13,124 Novo Nordisk shares in Q2 2026, an estimated $564K.
  • Novo Nordisk made up 0.16% of Abel Hall LLC's portfolio in Q2 2026, its #94 holding.
  • Abel Hall LLC first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • 484 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.